Can proteomics-based diagnostics aid clinical psychiatry?

Proteomics Clin Appl. 2015 Oct;9(9-10):885-8. doi: 10.1002/prca.201400144. Epub 2015 Apr 2.

Abstract

Despite major advances in infrastructure and instrumentation, proteomics-driven translational applications have not yet yielded the results that the scientific community has envisaged. In this viewpoint, the perspective of proteomics-based diagnostics in the field of clinical psychiatry is explored. The challenges that proteomics faces in the context of translational approaches are outlined and directions toward a successful clinical implementation are provided. Additional challenges that psychiatric disorders pose for clinical proteomics are highlighted and the potential of proteomics-based, blood tests for psychiatric disorders is being assessed. Proteomics offers a valuable toolkit for clinical translation that needs to be handled in a pragmatic manner and with realistic expectations.

Keywords: Blood tests; Clinical proteomics; Diagnostics; Implementation; Psychiatric disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Humans
  • Mental Disorders / diagnosis
  • Mental Disorders / metabolism
  • Proteomics / methods*
  • Psychiatry / methods*

Substances

  • Biomarkers